FIRN M is actively engaged in discovery, development, manufacturing and marketing of new interferon-based medicines. Scientists at FIRN M R&D Centre under supervision of Professor, Dr Med. Sci. Peter Gaponyuk have created the world’s first and unique liquid medical form of recombinant human interferon — Grippferon®, nasal drops; Ophtalmoferon®, eye drops; Herpferon®, ointment; Allergoferon®, gel; Allergoferon® beta, eye and nasal drops; Vagiferon®, suppositories; Micoferon® gel.